Renhe Weilai (Genetalks)
PrivateLast Round
Series A
Jul 1, 2017
Est. Valuation
$406.09M
Total Funding Raised
$36.92M
Company Overview
Renhe Weilai (Genetalks) operates in Healthcare & Life Sciences and is based in Changsha. Its latest recorded funding round was a Series A round in July 2017.
Renhe Weilai (Genetalks) is a biotechnology company that provides high-performance computing and artificial intelligence solutions for genetic big data analysis and management.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Renhe Weilai (Genetalks) Comparables
Compare Renhe Weilai (Genetalks) with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sentieon Inc. | 79% | |
| MGI | 77% | |
| DNAnexus | 77% |
For institutional investors. Book with your work email.
Renhe Weilai (Genetalks) Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Renhe Weilai (Genetalks) Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jiawo Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2017
$37M round led by Jiawo Capital.
For institutional investors. Book with your work email.
Renhe Weilai (Genetalks) Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Renhe Weilai (Genetalks)'s valuation, stock price, and market status.
Is Renhe Weilai (Genetalks) a public or private company?
Renhe Weilai (Genetalks) is a private company.
What is the current stock price of Renhe Weilai (Genetalks)?
Renhe Weilai (Genetalks) is a private company, so its shares have no public market price. Caplight tracks Renhe Weilai (Genetalks)'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Renhe Weilai (Genetalks) worth (valuation)?
Renhe Weilai (Genetalks)'s valuation is estimated at $406.1M based on funding round data.
Can I buy Renhe Weilai (Genetalks) stock?
Renhe Weilai (Genetalks) shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Renhe Weilai (Genetalks)'s last funding round?
Renhe Weilai (Genetalks)'s most recent funding round was Series A on July 1, 2017.
Who are the main investors in Renhe Weilai (Genetalks)?
Key investors in Renhe Weilai (Genetalks) include Jiawo Capital.
Will Renhe Weilai (Genetalks) IPO soon?
No public IPO plans have been announced for Renhe Weilai (Genetalks).
How can I track Renhe Weilai (Genetalks) secondary market activity?
Caplight tracks bids, offers, and trades in Renhe Weilai (Genetalks)'s shares on secondary markets.